These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7882292)

  • 1. Effect of the delivery system on the biodistribution of Ge(IV) octabutoxy-phthalocyanines in tumour-bearing mice.
    Soncin M; Polo L; Reddi E; Jori G; Kenney ME; Cheng G; Rodgers MA
    Cancer Lett; 1995 Feb; 89(1):101-6. PubMed ID: 7882292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines.
    Soncin M; Polo L; Reddi E; Jori G; Kenney ME; Cheng G; Rodgers MA
    Br J Cancer; 1995 Apr; 71(4):727-32. PubMed ID: 7710936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-localising and -photosensitizing properties of liposome-delivered Ge(IV)-octabutoxy-phthalocyanine.
    Cuomo V; Jori G; Rihter B; Kenney ME; Rodgers MA
    Br J Cancer; 1991 Jul; 64(1):93-5. PubMed ID: 1854632
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of delivery system on the pharmacokinetic and phototherapeutic properties of bis(methyloxyethyleneoxy) silicon-phthalocyanine in tumor-bearing mice.
    Wöhrle D; Muller S; Shopova M; Mantareva V; Spassova G; Vietri F; Ricchelli F; Jori G
    J Photochem Photobiol B; 1999 Jun; 50(2-3):124-8. PubMed ID: 10515076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and phototherapeutic properties of axially substituted Si(IV)-tetradibenzobarreleno-octabutoxyphthalocyanines.
    Soncin M; Busetti A; Reddi E; Jori G; Rither BD; Kenney ME; Rodgers MA
    J Photochem Photobiol B; 1997 Sep; 40(2):163-7. PubMed ID: 9345784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency.
    Reddi E; Zhou C; Biolo R; Menegaldo E; Jori G
    Br J Cancer; 1990 Mar; 61(3):407-11. PubMed ID: 2328207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours.
    Segalla A; Milanesi C; Jori G; Capraro HG; Isele U; Schieweck K
    Br J Cancer; 1994 May; 69(5):817-25. PubMed ID: 8180009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer.
    Boyle RW; Rousseau J; Kudrevich SV; Obochi M; van Lier JE
    Br J Cancer; 1996 Jan; 73(1):49-53. PubMed ID: 8554982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-localizing and tumour-photosensitizing properties of zinc(II)-octapentyl-phthalocyanine.
    Fabris C; Ometto C; Milanesi C; Jori G; Cook MJ; Russell DA
    J Photochem Photobiol B; 1997 Jul; 39(3):279-84. PubMed ID: 9253202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing pH-responsive polymeric micelles for drug delivery in a cancer photodynamic therapy model.
    Le Garrec D; Taillefer J; Van Lier JE; Lenaerts V; Leroux JC
    J Drug Target; 2002 Aug; 10(5):429-37. PubMed ID: 12442814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome-delivered 131I-labelled Zn(II)-phthalocyanine as a radiodiagnostic agent for tumours.
    Polo L; Segalla A; Jori G; Bocchiotti G; Verna G; Franceschini R; Mosca R; De Filippi PG
    Cancer Lett; 1996 Dec; 109(1-2):57-61. PubMed ID: 9020903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours.
    Allémann E; Brasseur N; Benrezzak O; Rousseau J; Kudrevich SV; Boyle RW; Leroux JC; Gurny R; Van Lier JE
    J Pharm Pharmacol; 1995 May; 47(5):382-7. PubMed ID: 7494187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of the selective retention of palladium octabutoxynaphthalocyanine, a potential photothermal drug, in mouse tissues.
    Bucking M; Gudgin Dickson EF; Farahani M; Fischer F; Holmes D; Jori G; Kennedy JC; Kenney ME; Peng X; Pottier RH; Weagle G
    J Photochem Photobiol B; 2000 Nov; 58(2-3):87-93. PubMed ID: 11233653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome-mediated delivery of photosensitizers: localization of zinc (II)-phthalocyanine within implanted tumors after intravenous administration.
    Love WG; Duk S; Biolo R; Jori G; Taylor PW
    Photochem Photobiol; 1996 May; 63(5):656-61. PubMed ID: 8628757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of fluorescence methods used in the pharmacokinetic studies of Zn(II)phthalocyanine in mice.
    Biolo R; Jori G; Kennedy JC; Nadeau P; Pottier R; Reddi E; Weagle G
    Photochem Photobiol; 1991 Jan; 53(1):113-8. PubMed ID: 2027900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic studies with zinc(II)-phthalocyanine in tumour-bearing mice.
    Reddi E; Lo Castro G; Biolo R; Jori G
    Br J Cancer; 1987 Nov; 56(5):597-600. PubMed ID: 3426922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles.
    Allémann E; Rousseau J; Brasseur N; Kudrevich SV; Lewis K; van Lier JE
    Int J Cancer; 1996 Jun; 66(6):821-4. PubMed ID: 8647656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo targeted delivery of photosensitizers to the tumor cells for enhanced photodynamic effects.
    Gupta S; Dwarakanath BS; Chaudhury NK; Mishra AK; Muralidhar K; Jain V
    J Cancer Res Ther; 2011; 7(3):314-24. PubMed ID: 22044814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells.
    Shao J; Dai Y; Zhao W; Xie J; Xue J; Ye J; Jia L
    Cancer Lett; 2013 Mar; 330(1):49-56. PubMed ID: 23200672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of a hydrophobic phthalocyanine photosensitizer using PEGylated gold nanoparticle conjugates for the in vivo photodynamic therapy of amelanotic melanoma.
    Camerin M; Moreno M; Marín MJ; Schofield CL; Chambrier I; Cook MJ; Coppellotti O; Jori G; Russell DA
    Photochem Photobiol Sci; 2016 May; 15(5):618-25. PubMed ID: 27064601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.